Overview

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of sulindac may prevent breast cancer. PURPOSE: This randomized phase I trial is studying the effects of sulindac, to prevent breast cancer, in women at high risk for breast cancer.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)
Collaborator:
University of Arizona
Treatments:
Sulindac